Case report: pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: not only a dasatinib-related adverse event

HIGHLIGHTS

• who: Raffaella Pasquale from the University of Udine, Italy have published the Article: Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event, in the Journal: (JOURNAL)
• what: In this case report, nilotinib was found to be the only possible cause of PE, after excluding other etiologies.

SUMMARY

BCR::ABL1-positive chronic myeloid leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1-2 cases per 100.000 adults, which represents approximately 15% of newly diagnosed cases of leukemia in . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.